Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease
- 22 February 2006
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 40 (3) , 251-258
- https://doi.org/10.1111/j.1600-079x.2005.00308.x
Abstract
In this study, the effects of melatonin on MPP+ -treated cerebellar granule neurons (CGNs) in culture were investigated. Results showed that MPP+ treatment significantly decreased cell viability and increased the apoptotic cell population at 24 and 48 hr. Calpain and caspase-3 activation was also determined, with results showing a strong increase in calpain (74%) and caspase 3 activity (70%), as measured by alpha-spectrin cleavage and fluorometric and colorimetric analysis, respectively. There are several studies suggesting that the activation of the cdk5/p35 pathway at its cleavage to cdk5/p25 may play a role in neuronal cell death in neurodegenerative diseases. Moreover, these studies indicate that this cleavage is mediated by calpains, and that MPP+ prompted an increase in cdk5 expression, as well as the cleavage of p35-p25, in a time-dependent manner. 1 mm Melatonin not only reduced the neurotoxic effects of MPP+ on cell viability, but also prevented apoptosis mediated by this Parkinsonian toxin in CGNs. 1 mm Melatonin reduced cdk5 expression, as well as the cleavage of p35-p25. These data indicate that melatonin possesses some neuro-protective properties against MPP+ -induced apoptosis. Moreover, these data suggest that the calpain/cdk5 signaling cascade has a potential role in the MPP+ -mediated apoptotic process in CGNs.Keywords
This publication has 42 references indexed in Scilit:
- A role for endocannabinoids in the generation of parkinsonism and levodopa‐induced dyskinesia in MPTP‐lesioned non‐human primate models of Parkinson's diseaseThe FASEB Journal, 2005
- Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitroJournal of Pineal Research, 2005
- Melatonin attenuates 1-methyl-4-phenylpyridinium-induced PC12 cell deathActa Pharmacologica Sinica, 2005
- CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's diseaseTrends in Molecular Medicine, 2004
- Protective effect of melatonin on 3‐nitropropionic acid‐induced oxidative stress in synaptosomes in an animal model of Huntington's diseaseJournal of Pineal Research, 2004
- Melatonin protects against oxidative stress caused by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the mouse nigrostriatumJournal of Pineal Research, 2003
- A Possible Stimulatory Effect of FMRFamide on Neural Nitric Oxide Production in the Central Nervous System of Helix lucorum L.Brain, Behavior and Evolution, 2003
- Parkinson's DiseaseNeuron, 2003
- 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxideBiochemical Journal, 2003
- Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entryNeuroReport, 2002